Columbus Macro LLC Acquires 11,022 Shares of Colgate-Palmolive Company $CL

Columbus Macro LLC lifted its holdings in Colgate-Palmolive Company (NYSE:CL) by 10.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 115,407 shares of the company’s stock after purchasing an additional 11,022 shares during the period. Colgate-Palmolive comprises 1.1% of Columbus Macro LLC’s holdings, making the stock its 29th biggest position. Columbus Macro LLC’s holdings in Colgate-Palmolive were worth $9,836,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Brighton Jones LLC raised its stake in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares in the last quarter. Woodline Partners LP lifted its holdings in Colgate-Palmolive by 76.3% during the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares during the period. Schnieders Capital Management LLC. boosted its position in Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after acquiring an additional 245 shares in the last quarter. Nebula Research & Development LLC boosted its position in Colgate-Palmolive by 165.5% during the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after acquiring an additional 6,437 shares in the last quarter. Finally, Sei Investments Co. increased its holdings in shares of Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after acquiring an additional 116,968 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.9%

Colgate-Palmolive stock opened at $91.06 on Friday. The stock has a 50-day moving average of $87.90 and a two-hundred day moving average of $87.01. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The stock has a market cap of $72.86 billion, a PE ratio of 35.43, a price-to-earnings-growth ratio of 4.84 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The company’s revenue was up 8.4% on a year-over-year basis. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analysts Set New Price Targets

Several research analysts have recently commented on CL shares. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Barclays lifted their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 5th. Weiss Ratings upgraded shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 8th. Finally, Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.